Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | |
---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | |||||||||
Cash from operating activities | 0.46%1.04B | 60.12%1.04B | 379.41%648.26M | -135.64%-232.01M | -6.33%651.07M | 10.12%695.08M | 23.19%631.22M | 67.14%512.39M | 306.57M |
Net profit before non-cash adjustment | 18.58%1.04B | 93.08%874.2M | 339.99%452.77M | -137.26%-188.67M | -26.32%506.37M | 20.49%687.29M | 34.71%570.41M | 31.07%423.45M | --323.07M |
Total adjustment of non-cash items | 17.07%67.47M | 51.86%57.64M | -41.53%37.95M | -36.95%64.91M | 173.20%102.94M | 17.38%37.68M | 38.42%32.1M | 4,951.46%23.19M | ---478K |
-Depreciation and amortization | 88.08%44.09M | 194.81%23.44M | -62.64%7.95M | -40.38%21.28M | 18.95%35.69M | 701.04%30.01M | -11.86%3.75M | -8.86%4.25M | --4.66M |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | -30.87%28.24M | --40.85M | ---- | ---- | ---- | ---- |
-Assets reserve and write-off | ---- | ---- | ---- | --4M | ---- | ---- | ---- | -326.34%-3.26M | --1.44M |
-Disposal profit | --0 | --4.01M | --0 | ---- | --10M | ---- | ---- | ---- | ---2.16M |
-Net exchange gains and losses | 402.50%201K | --40K | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
-Remuneration paid in stock | -67.00%10.57M | 32.61%32.04M | 30.31%24.17M | --18.54M | ---- | ---- | ---- | ---- | ---- |
-Deferred income tax | ---- | ---- | ---725K | --0 | ---- | ---- | ---- | ---- | ---- |
-Other non-cash items | 765.84%12.61M | -128.86%-1.89M | 191.69%6.56M | -143.65%-7.16M | 113.74%16.4M | -72.94%7.67M | 27.73%28.35M | 602.19%22.2M | ---4.42M |
Changes in working capital | -157.67%-61.24M | -32.60%106.18M | 245.53%157.53M | -359.23%-108.25M | 239.69%41.76M | -204.12%-29.89M | -56.34%28.71M | 510.42%65.75M | ---16.02M |
-Change in receivables | 54.38%-20.66M | -1,460.20%-45.28M | 91.00%-2.9M | -154.55%-32.23M | 202.48%59.08M | -480.34%-57.65M | -325.72%-9.93M | 117.90%4.4M | ---24.59M |
-Change in inventory | --0 | 200.00%993K | ---993K | --0 | ---- | ---- | ---- | ---- | ---- |
-Change in prepaid assets | -208.86%-7.53M | 72.19%-2.44M | -210.08%-8.77M | 80.42%-2.83M | -466.35%-14.44M | 188.30%3.94M | -766.60%-4.46M | -577.63%-515K | ---76K |
-Change in payables | -191.35%-77.01M | -25.49%84.3M | 362.30%113.14M | -649.60%-43.13M | 44.84%-5.75M | -146.61%-10.43M | 3,424.25%22.38M | 119.30%635K | ---3.29M |
-Change in accrued expense | 59.43%21.25M | 1,804.14%13.33M | -76.39%700K | 157.38%2.97M | 80.81%-5.17M | -452.53%-26.92M | -69.60%7.64M | 1,827.58%25.12M | ---1.45M |
-Provision for loans, leases and other losses | 140.87%1.07M | -228.09%-2.63M | -13.94%-801K | 91.94%-703K | -189.85%-8.72M | 62.24%9.7M | --5.98M | ---- | ---- |
-Changes in other current assets | -62.64%21.63M | 1.31%57.9M | 276.81%57.16M | -292.96%-32.33M | -67.45%16.75M | 623.69%51.47M | -80.31%7.11M | 169.78%36.11M | --13.39M |
Dividends paid (cash flow from operating activities) | |||||||||
Dividends received (cash flow from operating activities) | |||||||||
Interest paid (cash flow from operating activities) | 87.88%-4K | 52.86%-33K | -70K | ||||||
Interest received (cash flow from operating activities) | 12.82%44K | -7.14%39K | 200.00%42K | -60.00%14K | 2.94%35K | 41.67%34K | -48.94%24K | -59.83%47K | 117K |
Tax refund paid | -57.76%-298.76M | -298.97%-189.38M | 150.81%95.18M | 26.10%-187.33M | -3.35%-253.48M | -31.14%-245.27M | -31.42%-187.03M | -214.43%-142.31M | -45.26M |
Other operating cash inflow (outflow) | -211.90%-1.9M | 88.46%1.7M | -93.25%901K | 13.36M | 0 | -200.00%-1K | 1K | 0 | 1K |
Operating cash flow | -12.72%742.2M | 14.24%850.37M | 283.36%744.39M | -202.11%-405.98M | -11.60%397.59M | 1.25%449.77M | 20.02%444.22M | 41.58%370.13M | --261.43M |
Investing cash flow | |||||||||
Net PPE purchase and sale | -9.62%-20.39M | -5,863.14%-18.61M | ---312K | --0 | ---39.34M | ---- | -2,313.17%-4.95M | ---205K | ---- |
Net intangibles purchase and sale | ---- | ---- | ---- | ---4.4M | ---- | ---- | ---- | ---- | ---- |
Net business purchase and sale | ---475M | --0 | ---- | --112K | ---- | ---- | ---123.83M | ---- | --2.16M |
Net investment product transactions | 100.01%1K | -114.49%-17.4M | 600.10%120.05M | 7.69%-24M | 23.52%-26.01M | -54.54%-34M | ---22M | ---- | ---- |
Net changes in other investments | -212.34%-35.14M | 347,500.00%31.28M | -96.44%9K | 112.29%253K | 97.03%-2.06M | -2,914.15%-69.24M | -128.38%-2.3M | 215.49%8.1M | ---7.01M |
Investing cash flow | -11,142.55%-530.54M | -103.94%-4.72M | 527.06%119.74M | 58.40%-28.04M | 34.71%-67.4M | 32.56%-103.24M | -2,040.19%-153.08M | 262.71%7.89M | ---4.85M |
Financing cash flow | |||||||||
Net issuance payments of debt | ---- | ---- | ---- | 64.02%-708K | 0.00%-1.97M | ---1.97M | ---- | ---- | ---- |
Net common stock issuance | --49.07M | --0 | ---- | -634.42%-50.44M | 104.79%9.44M | -2,671.36%-196.89M | -99.21%7.66M | --965.65M | ---- |
Issuance fees | ---- | ---- | ---- | ---- | ---- | ---- | ---24.66M | ---- | ---- |
Net other fund-raising expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---16.28M | ---- |
Financing cash flow | --49.07M | --0 | ---- | -784.70%-51.15M | 103.76%7.47M | -1,069.61%-198.86M | -101.79%-17M | --949.37M | --0 |
Net cash flow | |||||||||
Beginning cash position | 27.84%3.88B | 39.75%3.04B | -18.25%2.17B | 14.55%2.66B | 6.79%2.32B | 14.43%2.17B | 232.05%1.9B | 81.34%572.02M | --315.44M |
Current changes in cash | -69.17%260.73M | -2.14%845.66M | 278.11%864.13M | -243.68%-485.16M | 128.65%337.66M | -46.13%147.68M | -79.35%274.14M | 417.34%1.33B | --256.58M |
Cash adjustments other than cash changes | ---- | --1K | ---- | -200.00%-1K | --1K | ---- | -133.33%-1K | 400.00%3K | ---1K |
End cash Position | 6.71%4.14B | 27.84%3.88B | 39.75%3.04B | -18.25%2.17B | 14.55%2.66B | 6.79%2.32B | 14.43%2.17B | 232.05%1.9B | --572.02M |
Free cash flow | -13.22%721.8M | 11.79%831.77M | 281.31%744.07M | -214.55%-410.38M | -20.35%358.26M | 2.39%449.77M | 18.75%439.27M | 41.50%369.92M | --261.43M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |